PRCT

20.89

5.77% 1.14

Dopo l'orario di chiusura: 20.89

Procept Biorobotics Corp (PRCT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$19.75

Aprire:

$20.13

Volume 24 ore:

1.23M

Relative Volume:

0.80

Capitalizzazione di mercato:

$1.19B

Reddito:

$322.02M

Utile/perdita netta:

$-102.47M

Rapporto P/E:

-11.42

EPS:

-1.8295

Flusso di cassa netto:

$-80.57M

1 W Prestazione:

-0.67%

1M Prestazione:

-28.19%

6M Prestazione:

-36.37%

1 anno Prestazione:

-64.72%

Intervallo 1D:

$19.63

$21.00

Intervallo di 1 settimana:

$19.55

$21.88

Portata 52W:

$19.35

$62.17

Procept Biorobotics Corp Stock (PRCT) Company Profile

Nome

Procept Biorobotics Corp

Settore

Healthcare (1096)

Industria

Medical Devices (140)

Telefono

(650) 232-9832

Indirizzo

150 BAYTECH DRIVE, SAN JOSE

Dipendente

888

Cinguettio

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

PRCT's Discussions on Twitter

Compare PRCT vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PRCT Procept Biorobotics Corp	20.89	1.19B	322.02M	-102.47M	-80.57M	-1.8295
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-06	Iniziato	Robert W. Baird	Neutral
2026-02-26	Downgrade	BofA Securities	Neutral → Underperform
2026-02-26	Downgrade	Oppenheimer	Outperform → Perform
2025-12-12	Iniziato	UBS	Buy
2025-12-08	Downgrade	BofA Securities	Buy → Neutral
2025-09-02	Aggiornamento	Oppenheimer	Perform → Outperform
2025-07-09	Iniziato	Stephens	Overweight
2025-07-07	Iniziato	Oppenheimer	Perform
2024-12-02	Iniziato	Morgan Stanley	Overweight
2024-11-14	Iniziato	Jefferies	Hold
2023-08-11	Iniziato	Piper Sandler	Overweight
2023-05-31	Iniziato	William Blair	Outperform
2022-10-31	Iniziato	BTIG Research	Neutral
2022-10-25	Iniziato	Truist	Buy
2022-09-02	Iniziato	Wells Fargo	Overweight
2022-07-15	Iniziato	KeyBanc Capital Markets	Overweight
2022-06-23	Iniziato	B. Riley Securities	Buy
2021-10-11	Iniziato	BofA Securities	Buy
2021-10-11	Iniziato	Cowen	Outperform
2021-10-11	Iniziato	Goldman	Neutral
2021-10-11	Iniziato	Guggenheim	Buy
2021-10-11	Iniziato	SVB Leerink	Outperform

Mostra tutto

Procept Biorobotics Corp Borsa (PRCT) Ultime notizie

Jul 10, 2026

Pooja Sharma Net Worth (2026) - GuruFocus

Jul 10, 2026

Jul 09, 2026

Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN

Jul 09, 2026

Jul 07, 2026

Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail

Jul 07, 2026

PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS

Jul 07, 2026

Jul 06, 2026

Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com

Jul 06, 2026

Jul 05, 2026

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits

Jul 05, 2026

Jul 03, 2026

PRCTProcept BioRobotics Corp Dividends - Finviz

Jul 03, 2026

Jul 02, 2026

Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com South Africa

Jul 02, 2026

Truist cuts Procept BioRobotics stock rating on reimbursement concerns - Investing.com

Jul 02, 2026

PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - simplywall.st

Jul 02, 2026

Jun 30, 2026

PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation’s Oncology Potential – Has The Bull Case Changed? - simplywall.st

Jun 30, 2026

Jun 29, 2026

Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential - Insider Monkey

Jun 29, 2026

Price to book forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 29, 2026

Jun 28, 2026

Price to sales forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 28, 2026

Jun 27, 2026

Enterprise value to EBITDA forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView

Jun 27, 2026

Price to sales forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView

Jun 27, 2026

Enterprise value to EBIT forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView

Jun 27, 2026

Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now - Insider Monkey

Jun 25, 2026

Jun 24, 2026

Evercore ISI initiates Procept BioRobotics stock with outperform rating - Investing.com UK

Jun 24, 2026

Evercore ISI initiates Procept BioRobotics stock with outperform rating By Investing.com - Investing.com Australia

Jun 24, 2026

5 Best Robotics and Automation Stocks to Invest In - Insider Monkey

Jun 24, 2026

Jun 23, 2026

PROCEPT BioRobotics (PRCT) Is Down 6.5% After Institutional Ownership Surges Past Shares Outstanding Has The Bull Case Changed? - simplywall.st

Jun 23, 2026

Jun 20, 2026

PROCEPT BioRobotics (PRCT) Stock Could Be 14% Undervalued After Growth Outlook Holds - simplywall.st

Jun 20, 2026

Jun 19, 2026

Transcript : PROCEPT BioRobotics Corporation Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 12 - marketscreener.com

Jun 19, 2026

Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now? - Insider Monkey

Jun 19, 2026

Jun 18, 2026

Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga

Jun 18, 2026

Jun 17, 2026